Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.

The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Abstract Text:

    liana r merzLiana R Merz,david k warrenDavid K Warren,marin h kollefMarin H Kollef,scott k fridkinScott K Fridkin,victoria j fraserVictoria J Fraser,

    BACKGROUND: Antimicrobial-resistant organisms are an emerging problem in the ICU. Therapy cycling empiric antibiotics between various classes may influence bacterial resistance patterns. Understanding the impact of cycling on the appropriate treatment of suspected Gram-negative infections is important. METHODS: Data were prospectively collected on patients who were admitted to a 19-bed medical ICU (MICU). A total of 1,172 patients were admitted to the MICU for > 48 h and were evaluated during a 28.5-month period. After 4.5 months of baseline data collection, an antibiotic-cycling protocol was implemented, using four different antibiotic classes with Gram-negative activity that were cycled every 3 to 4 months. Therapy was considered to be inappropriate if the subsequent bacterial isolate was resistant to the empiric drug used. RESULTS: There were 59 bloodstream infections (BSIs), 17 ventilator-associated pneumonias (VAPs), and 101 urinary tract infections (UTIs) involving Gram-negative bacteria among 139 patients. Fifty-five infections (31%) were due to Gram-negative bacteria resistant to one or more antibiotic agents (BSIs, 18 [30%]; VAPs, 4 [23%]; and UTIs, 33 [33%]). Fifteen patients received inappropriate empiral therapy for 18 resistant Gram-negative infections (BSIs, 7 [39%]; VAPs, 3 [75%]; UTIs, 8 [24%]). Patients receiving inappropriate therapy were more likely to die (10 patients [67%] vs 40 patients [32%], respectively; p < 0.01). There was no difference in the receipt of appropriate empirical antibiotic therapy during the baseline compared to cycling (infectious episodes, 15% vs 10%, respectively; p = 0.4). CONCLUSIONS: Antimicrobial resistance occurred in almost 30% of ICU infections involving Gram-negative bacteria. Antibiotic cycling was not associated with significant changes in the receipt of appropriate empirical antimicrobial therapy for the treatment of ICU infections.

    The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Publishing Authors By Initials

    lr merzLR Merz,dk warrenDK Warren,mh kollefMH Kollef,sk fridkinSK Fridkin,vj fraserVJ Fraser,

    For similar organic chemicals: amides: lactams: beta-lactams research abstracts see: organic chemicals: amides: lactams: beta-lactams research

    PUBMED ID PMID:

    MEDLINE DATE:

    The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Chest

    VOLUME: 130

    Page Numbers: 1672-8

    Journal Abbreviation: Chest

    ISSN: 0012-3692

    DAY: 3

    MONTH: Dec

    YEAR: 2006

    The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 231335

    The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Keywords Mesh Terms:

    KEYWORDS: beta-Lactams

    MESH TERMS: administration & dosage

    Chemical & Substance for Abstract: The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Information

    Substance Name: beta-Lactams

    Registry Number: 0

    Grant and Affiliation Information for The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.

    AFFILIATION: Division of Infectious Diseases, Washington University School of Medicine, Box 8051, 660 S Euclid Ave., Saint Louis, MO 63110, USA. lmerz@im.wustl.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States PHS

    GRANT: UR8/CCU 715087

    ACRONYM: AI

    MEDLINETA: Chest

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The impact of an antibiotic cycling program on empirical therapy for gram-negative infections Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News